Training Data The Quest to ‘Solve All Diseases’ with AI: Isomorphic Labs’ Max Jaderberg
92 snips
Apr 29, 2025 
Max Jaderberg, Chief AI Officer of Isomorphic Labs and former DeepMind pioneer, discusses revolutionary advancements in drug discovery with AI. He highlights AlphaFold 3's potential to redefine molecular understanding and predicts we are nearing a 'Move 37 moment', where AI can surpass human intuition in drug design. Jaderberg envisions general AI capable of solving all diseases, emphasizing the need for innovative agents to navigate the vast potential of molecular designs, revolutionizing both biology and pharmacology.
AI Snips
Chapters
Transcript
Episode notes
Capture the Flag Breakthrough
- Capture the Flag was used as a multiplayer game to explore generalization and multi-agent dynamics in reinforcement learning.
- This approach pushed AI to achieve human-level performance in complex, dynamic environments.
General AI Drug Design Engine
- Isomorphic Labs aims to build a general AI-driven drug design engine applicable across all diseases and modalities.
- This approach contrasts with targeting specific diseases or molecules, focusing instead on broad generalization.
Navigating Vast Molecular Space
- Even with perfect predictive models, the vast molecular space (up to 10^60 molecules) makes exhaustive search impossible.
- AI needs generative models and agents to efficiently explore this massive design landscape.